127 related articles for article (PubMed ID: 33538330)
1. Prognostic Significance of Systemic Inflammatory Response in Cases of Temporal Bone Squamous Cell Carcinoma.
Komune N; Sato K; Hongo T; Miyazaki M; Masuda S; Koike K; Uchi R; Tsuchihashi NA; Noda T; Kogo R; Wakasaki T; Yasumatsu R; Nakagawa T
Laryngoscope; 2021 Aug; 131(8):1782-1789. PubMed ID: 33538330
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
3. Temporal bone squamous cell carcinoma: analyzing prognosis with univariate and multivariate models.
Zanoletti E; Marioni G; Stritoni P; Lionello M; Giacomelli L; Martini A; Mazzoni A
Laryngoscope; 2014 May; 124(5):1192-8. PubMed ID: 24108656
[TBL] [Abstract][Full Text] [Related]
4. Primary Advanced Squamous Cell Carcinoma of the Temporal Bone: A Single-Center Clinical Study.
Komune N; Noda T; Kogo R; Miyazaki M; Tsuchihashi NA; Hongo T; Koike K; Sato K; Uchi R; Wakasaki T; Matsumoto N; Yasumatsu R; Nakagawa T
Laryngoscope; 2021 Feb; 131(2):E583-E589. PubMed ID: 32267551
[TBL] [Abstract][Full Text] [Related]
5. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
6. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
7. Preoperative circulating platelet, neutrophil, and lymphocyte counts predict survival in oral cancer.
Diao P; Wu Y; Ge H; Li J; Zhang W; Huang R; Wang Y; Cheng J
Oral Dis; 2019 May; 25(4):1057-1066. PubMed ID: 30697882
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma.
Farhan-Alanie OM; McMahon J; McMillan DC
Br J Oral Maxillofac Surg; 2015 Feb; 53(2):126-31. PubMed ID: 25440150
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis.
Sano Y; Kogashiwa Y; Araki R; Enoki Y; Ikeda T; Yoda T; Nakahira M; Sugasawa M
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):667-676. PubMed ID: 29359615
[TBL] [Abstract][Full Text] [Related]
10. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
13. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
Xu XL; Yu HQ; Hu W; Song Q; Mao WM
PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
[TBL] [Abstract][Full Text] [Related]
14. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
[TBL] [Abstract][Full Text] [Related]
15. A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.
Hirahara N; Tajima Y; Fujii Y; Yamamoto T; Hyakudomi R; Hirayama T; Taniura T; Ishitobi K; Kidani A; Kawabata Y
World J Surg; 2018 Jan; 42(1):172-184. PubMed ID: 28744596
[TBL] [Abstract][Full Text] [Related]
16. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
19. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
Zhang Y; Jiang C; Li J; Sun J; Qu X
Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]